Would you like to contribute to the safe use of medicines and vaccines globally? We are looking for a Content Specialist to join one of our Content Management teams in the Portfolio and Product Management department.
Since 1978, Uppsala Monitoring Centre (UMC) has been dedicated to developing, supporting, and expanding the field of pharmacovigilance science and practice.
As a World Health Organization (WHO) Collaborating Centre, we support work around the world to examine the potential adverse effects of medicines and vaccines and contribute to safer, more informed care of patients.
We are a diverse, international group of pharmacists, physicians, data scientists, system developers, communicators, and many other professionals motivated by a deep belief that the work we do matters.
About the role
The two Content Management teams mainly consist of pharmacists responsible for developing and maintaining the WHODrug product portfolio, including WHODrug Global, the world’s most widely used drug dictionary. The teams ensure high-quality, regulatory-compliant content that supports customer needs, in close collaboration with WHODrug Portfolio Management. The teams also partake in the development of processes and systems for creating the Pharmaceutical Product ID (PhPID) and Global Substance ID (GSID) in line with the ISO Identification of Medicinal Products (IDMP) standards.
The position will be placed in one of the Content Management teams based on the profile and background of the selected candidate.
What you will do
Further into the employment, you will have the opportunity to participate in the maintenance of PHPID or WHODrug related products and services, other aspects of the team´s responsibilities.
Who you are
You may be the right person for this role if you have:
It is an advantage if you also have:
As a person, you:
The role requires working on site at the Uppsala office at least three days per week.
Interviews will be held on an ongoing basis during the application period.
#LI-DNI

Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports.
In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.